Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy
- PMID: 31861591
- PMCID: PMC7019297
- DOI: 10.3390/jcm9010015
Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy
Abstract
Focusing on previously published mechanisms of non-alcoholic fatty liver disease (NAFLD), their uncertainty does not always permit a clear elucidation of the grassroot alterations that are at the basis of the wide-spread illness, and thus curing it is still a challenge. There is somehow exceptional progress, but many controversies persist in NAFLD research and clinical investigation. It is likely that hidden mechanisms will be brought to light in the near future. Hereby, the authors present, with some criticism, classical mechanisms that stand at the basis of NAFLD, and consider contextually different emerging processes. Without ascertaining these complex interactions, investigators have a long way left ahead before finding an effective therapy for NAFLD beyond diet and exercise.
Keywords: IR; NAFLD; NASH; ROS; inflammation; obesity.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology.Yeungnam Univ J Med. 2019 May;36(2):67-77. doi: 10.12701/yujm.2019.00171. Epub 2019 Apr 11. Yeungnam Univ J Med. 2019. PMID: 31620616 Free PMC article. Review.
-
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1. Yakugaku Zasshi. 2019. PMID: 31474630 Review. Japanese.
-
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.Int J Mol Sci. 2016 Aug 23;17(9):1379. doi: 10.3390/ijms17091379. Int J Mol Sci. 2016. PMID: 27563875 Free PMC article. Review.
-
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777. World J Gastroenterol. 2015. PMID: 25852263 Free PMC article. Review.
-
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. World J Gastroenterol. 2014. PMID: 25400438 Free PMC article. Review.
Cited by
-
Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases-A comprehensive narrative review.Food Sci Nutr. 2024 Feb 16;12(5):3097-3111. doi: 10.1002/fsn3.4010. eCollection 2024 May. Food Sci Nutr. 2024. PMID: 38726410 Free PMC article. Review.
-
Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver.Pharmaceuticals (Basel). 2024 Feb 7;17(2):220. doi: 10.3390/ph17020220. Pharmaceuticals (Basel). 2024. PMID: 38399435 Free PMC article.
-
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease.Nutr Metab (Lond). 2024 Jan 2;21(1):1. doi: 10.1186/s12986-023-00775-8. Nutr Metab (Lond). 2024. PMID: 38169398 Free PMC article.
-
The effects of intermittent fasting diet in comparison with low-calorie diet on lipid profile, glycemic status, and liver fibrosis in patients with non-alcoholic fatty liver (NAFLD): a study protocol for a randomized controlled clinical trial.BMC Nutr. 2023 Dec 8;9(1):145. doi: 10.1186/s40795-023-00794-x. BMC Nutr. 2023. PMID: 38066628 Free PMC article.
-
Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer.Eur J Med Res. 2023 Sep 21;28(1):360. doi: 10.1186/s40001-023-01334-w. Eur J Med Res. 2023. PMID: 37735699 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources